MucoLock oral gel device clinical trial for stomatitis, burning mouth, pain
Summary
The National Library of Medicine registered clinical trial NCT07506018 on ClinicalTrials.gov, evaluating the MucoLock oral gel device for treatment of stomatitis, burning mouth, and pain. The trial is registered as an interventional study without specified blinding or control group details. Healthcare providers conducting related research may reference this registration for patient referral or complementary study planning.
What changed
NLM registered a new clinical trial (NCT07506018) on ClinicalTrials.gov for the MucoLock oral gel device, an oral medical device under investigation for treating stomatitis, burning mouth syndrome, and oral pain. The registration documents the study design, eligibility criteria, and investigator information as required for compliant clinical trial registration.
Healthcare providers treating patients with stomatitis or burning mouth syndrome should be aware of this active trial for potential patient referrals. Medical device manufacturers in the oral care space may reference this registration when assessing the competitive research landscape. Clinical operations teams should verify their institution's IRB approval status aligns with trial participation requirements.
Source document (simplified)
Show glossary
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ClinicalTrials.gov publishes new changes.